Characterization of a New Chronic Lymphocytic Leukemia Cell Line for Mechanistic In Vitro and In Vivo Studies Relevant to Disease

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Hertlein, Erin ^a   Beckwith, Kyle A ^a   Lozanski, Gerard ^b   Chen, Timothy L ^a   Towns, William H ^a   Johnson, Amy J ^a   Lehman, Amy ^b   Ruppert, Amy S ^a   Bolon, Brad ^b   Andritsos, Leslie ^a   Lozanski, Arletta ^a   Rassenti, Laura ^c   Zhao, Weiqiang ^b   Jarvinen, Tiina M ^a   Senter, Leigha ^a   Croce, Carlo M ^a   Symer, David E ^a   de la Chapelle, Albert ^a   Heerema, Nyla A ^b   Byrd, John C ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD5 ANTIGEN; CHEMOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CELL MIGRATION; CHROMOSOME 12; CHROMOSOME 19; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CYTOGENETICS; ENGRAFTMENT; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL LINE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OSU CLL CELL LINE; TRISOMY; TRISOMY 12; TRISOMY 19;

ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL MOVEMENT; CELL TRANSFORMATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MICE; PHENOTYPE;

EID: 84885119085     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076607     Document Type: Article

References (47)

1. Berkova A, Zemanova Z, Trneny M, Schwarz J, Karban J, et al. (2009) Clonal evolution in chronic lymphocytic leukemia studied by interphase fluorescence in-situ hybridization. Neoplasma 56: 455-458. doi:10.4149/neo_2009_05_455. PubMed: 19580349.
2. Cavazzini F, Rizzotto L, Sofritti O, Daghia G, Cibien F, et al. (2012) Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients. Leuk Lymphoma 53: 83-88. doi:10.3109/10428194.2011.606384. PubMed: 21767243.
3. Janssens A, Van Roy N, Poppe B, Noens L, Philippé J, et al. (2012) High-risk clonal evolution in chronic B-lymphocytic leukemia: single-center interphase fluorescence in situ hybridization study and review of the literature. Eur J Haematol 89: 72-80. doi:10.1111/j.1600-0609.2012.01790.x. PubMed: 22509718.
4. Loscertales J, Arranz E, Sanz MA, Blas C, Gil-Fernández JJ, et al. (2010) Clonal evolution in patients with chronic lymphocytic leukemia. Leuk Lymphoma 51: 1142-1143. doi:10.3109/10428191003793374. PubMed: 20443678.
5. Shanafelt TD, Hanson C, Dewald GW, Witzig TE, LaPlant B, et al. (2008) Karyotype evolution on fluorescent in situ hybridization analysis is associated with short survival in patients with chronic lymphocytic leukemia and is related to CD49d expression. J Clin Oncol 26: e5-e6. doi:10.1200/JCO.2008.16.7874. PubMed: 18467710.
6. Shanafelt TD, Witzig TE, Fink SR, Jenkins RB, Paternoster SF, et al. (2006) Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia. J Clin Oncol 24: 4634-4641. doi:10.1200/JCO.2006.06.9492. PubMed: 17008705.
7. Stilgenbauer S, Sander S, Bullinger L, Benner A, Leupolt E, et al. (2007) Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival. Haematologica 92: 1242-1245. doi:10.3324/haematol.10720. PubMed: 17666364.
8. Richardson SJ, Matthews C, Catherwood MA, Alexander HD, Carey BS, et al. (2006) ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL). Blood 107: 3584-3592. doi:10.1182/blood-2005-04-1718. PubMed: 16332969.
9. Bazargan A, Tam CS, Keating MJ, (2012) Predicting survival in chronic lymphocytic leukemia. Expert Rev Anticancer Ther 12: 393-403. doi:10.1586/era.12.2. PubMed: 22369330.
10. Kharfan-Dabaja MA, Chavez JC, Khorfan KA, Pinilla-Ibarz J, (2008) Clinical and therapeutic implications of the mutational status of IgVH in patients with chronic lymphocytic leukemia. Cancer 113: 897-906. doi:10.1002/cncr.23671. PubMed: 18618518.
11. Haslinger C, Schweifer N, Stilgenbauer S, Döhner H, Lichter P, et al. (2004) Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status. J Clin Oncol 22: 3937-3949. doi:10.1200/JCO.2004.12.133. PubMed: 15459216.
12. Joshi AD, Hegde GV, Dickinson JD, Mittal AK, Lynch JC, et al. (2007) ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia. Clin Cancer Res 13: 5295-5304. doi:10.1158/1078-0432.CCR-07-0283. PubMed: 17875758.
13. Wang J, Coombes KR, Highsmith WE, Keating MJ, Abruzzo LV, (2004) Differences in gene expression between B-cell chronic lymphocytic leukemia and normal B cells: a meta-analysis of three microarray studies. Bioinformatics 20: 3166-3178. doi:10.1093/bioinformatics/bth381. PubMed: 15231529.
14. Li S, Moffett HF, Lu J, Werner L, Zhang H, et al. (2011) MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cells. PLOS ONE 6: e16956. doi:10.1371/journal.pone.0016956. PubMed: 21408091.
15. Lanemo Myhrinder A, Hellqvist E, Bergh AC, Jansson M, Nilsson K, et al. (2013) Molecular characterization of neoplastic and normal "sister" lymphoblastoid B-cell lines from chronic lymphocytic leukemia. Leuk: Lymphoma. PubMed: 2329779918223168.
16. Avila-Cariño J, Lewin N, Tomita Y, Szeles A, Sandlund A, et al. (1997) B-CLL cells with unusual properties. Int J Cancer 70: 1-8. doi:10.1002/(SICI)1097-0215(19970106)70:1. PubMed: 8985083.
17. Takada K, Yamamoto K, Osato T, (1980) Analysis of the transformation of human lymphocytes by Epstein-Barr virus. II. Abortive response of leukemic cells to the transforming virus. Intervirology 13: 223-231. doi:10.1159/000149129. PubMed: 6248483.
18. Walls EV, Doyle MG, Patel KK, Allday MJ, Catovsky D, et al. (1989) Activation and immortalization of leukaemic B cells by Epstein-Barr virus. Int J Cancer 44: 846-853. doi:10.1002/ijc.2910440517. PubMed: 2555307.
19. Stacchini A, Aragno M, Vallario A, Alfarano A, Circosta P, et al. (1999) MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation. Leuk Res 23: 127-136. doi:10.1016/S0145-2126(98)00154-4. PubMed: 10071128.
20. Rosén A, Bergh AC, Gogok P, Evaldsson C, Myhrinder AL, et al. (2012) Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infection. Oncoimmunology 1: 18-27. doi:10.4161/onci.1.1.18400. PubMed: 22720208.
21. Wendel-Hansen V, Sällström J, De Campos-Lima PO, Kjellström G, Sandlund A, et al. (1994) Epstein-Barr virus (EBV) can immortalize B-cll cells activated by cytokines. Leukemia 8: 476-484. PubMed: 8127151.
22. Hwang KK, Chen X, Kozink DM, Gustilo M, Marshall DJ, et al. (2012) Enhanced outgrowth of EBV-transformed chronic lymphocytic leukemia B cells mediated by coculture with macrophage feeder cells. Blood 119: e35-e44. doi:10.1182/blood-2011-08-371203. PubMed: 22160618.
23. Muthusamy N, Breidenbach H, Andritsos L, Flynn J, Jones J, et al. (2011) Enhanced detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide in combination with pokeweed mitogen and phorbol myristate acetate. Cancer Genet 204: 77-83. doi:10.1016/j.cancergen.2010.12.006. PubMed: 21494579.
24. Capello D, Guarini A, Berra E, Mauro FR, Rossi D, et al. (2004) Evidence of biased immunoglobulin variable gene usage in highly stable B-cell chronic lymphocytic leukemia. Leukemia 18: 1941-1947. doi:10.1038/sj.leu.2403537. PubMed: 15483675.
25. Ghia EM, Jain S, Widhopf GF 2nd, Rassenti LZ, Keating MJ, et al. (2008) Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection. Blood 111: 5101-5108. doi:10.1182/blood-2007-12-130229. PubMed: 18326815.
26. Langerak AW, Davi F, Ghia P, Hadzidimitriou A, Murray F, et al. (2011) Immunoglobulin sequence analysis and prognostication in CLL: guidelines from the ERIC review board for reliable interpretation of problematic cases. Leukemia 25: 979-984. doi:10.1038/leu.2011.49. PubMed: 21455216.
27. Landau DA, Carter SL, Stojanov P, McKenna A, Stevenson K, et al. (2013) Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 152: 714-726. doi:10.1016/j.cell.2013.01.019. PubMed: 23415222.
28. Puente XS, Pinyol M, Quesada V, Conde L, Ordóñez GR, et al. (2011) Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475: 101-105. doi:10.1038/nature10113. PubMed: 21642962.
29. Quesada V, Conde L, Villamor N, Ordóñez GR, Jares P, et al. (2012) Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 44: 47-52. PubMed: 22158541.
30. Lozanski G, Ruppert AS, Heerema NA, Lozanski A, Lucas DM, et al. (2012) Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study. Leuk Lymphoma 53: 1743-1748. doi:10.3109/10428194.2012.668683. PubMed: 22369572.
31. Hertlein E, Wagner AJ, Jones J, Lin TS, Maddocks KJ, et al. (2010) 17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibition. Blood 116: 45-53. doi:10.1182/blood-2010-01-263756. PubMed: 20351313.
32. Khinkis LA, Levasseur L, Faessel H, Greco WR, (2003) Optimal design for estimating parameters of the 4-parameter hill model. Nonlinearity Biol Toxicol Med 1: 363-377. doi:10.1080/15401420390249925. PubMed: 19330140.
33. Erdfelder F, Hertweck M, Filipovich A, Uhrmacher S, Kreuzer KA, (2010) High lymphoid enhancer-binding factor-1 expression is associated with disease progression and poor prognosis in chronic lymphocytic leukemia. Hematol Rep 2: e3. PubMed: 22184516.
34. Gutierrez A Jr., Tschumper RC, Wu X, Shanafelt TD, Eckel-Passow J, et al. (2010) LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis. Blood 116: 2975-2983. doi:10.1182/blood-2010-02-269878. PubMed: 20595513.
35. Burger JA, Burger M, Kipps TJ, (1999) Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells. Blood 94: 3658-3667. PubMed: 10572077.
36. Romano MF, Festa M, Pagliuca G, Lerose R, Bisogni R, et al. (2003) BAG3 protein controls B-chronic lymphocytic leukaemia cell apoptosis. Cell Death Differ 10: 383-385. doi:10.1038/sj.cdd.4401167. PubMed: 12700638.
37. Porpaczy E, Bilban M, Heinze G, Gruber M, Vanura K, et al. (2009) Gene expression signature of chronic lymphocytic leukaemia with Trisomy 12. Eur J Clin Invest 39: 568-575. doi:10.1111/j.1365-2362.2009.02146.x. PubMed: 19453646.
38. Hoellenriegel J, Meadows SA, Sivina M, Wierda WG, Kantarjian H, et al. (2011) The phosphoinositide 3'-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia. Blood 118: 3603-3612. doi:10.1182/blood-2011-05-352492. PubMed: 21803855.
39. Lacerda JF, Ladanyi M, Jagiello C, O'Reilly RJ, (1996) Administration of rabbit anti-asialo GM1 antiserum facilitates the development of human Epstein-Barr virus-induced lymphoproliferations in xenografted C.B-17 scid/scid mice. Transplantation 61: 492-497. doi:10.1097/00007890-199602150-00030. PubMed: 8610366.
40. Villamor N, Conde L, Martínez-Trillos A, Cazorla M, Navarro A, et al. (2013) NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome. Leukemia, 27: 1100-6. PubMed: 23295735.
41. Kardava L, Yang Q, St Leger A, Foon KA, Lentzsch S, et al. (2011) The B lineage transcription factor E2A regulates apoptosis in chronic lymphocytic leukemia (CLL) cells. Int Immunol 23: 375-384. doi:10.1093/intimm/dxr027. PubMed: 21551245.
42. Mittal AK, Hegde GV, Aoun P, Bociek RG, Dave BJ, et al. (2007) Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities. Int J Mol Med 20: 461-469. PubMed: 17786276.
43. Ponader S, Chen SS, Buggy JJ, Balakrishnan K, Gandhi V, et al. (2012) The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo. Blood 119: 1182-1189. doi:10.1182/blood-2011-10-386417. PubMed: 22180443.
44. Bertilaccio MT, Scielzo C, Simonetti G, Ponzoni M, Apollonio B, et al. (2010) A novel Rag2-/-gammac-/--xenograft model of human CLL. Blood 115: 1605-1609. doi:10.1182/blood-2009-05-223586. PubMed: 20018917.
45. Kawata A, Han T, Dadey B, Weier HU, Okazaki M, et al. (1993) Establishment and characterization of the tumors of chronic lymphocytic leukemia cell line in nude and SCID mice. Leuk Res 17: 883-894. doi:10.1016/0145-2126(93)90154-D. PubMed: 8412300.
46. Lee CL, Uniyal S, Fernandez LA, Lee SH, Ghose T, (1986) Growth and spread in nude mice of Epstein-Barr virus transformed B-cells from a chronic lymphocytic leukemia patient. Cancer Res 46: 2497-2501. PubMed: 3008990.
47. Loisel S, Ster KL, Quintin-Roue I, Pers JO, Bordron A, et al. (2005) Establishment of a novel human B-CLL-like xenograft model in nude mouse. Leuk Res 29: 1347-1352. doi:10.1016/j.leukres.2005.04.017. PubMed: 15896841.